Li-Fraumeni syndrome

[1] Association of the germline TP53 R337H mutation with breast cancer in southern Brazil [J]. BMC CANCER, 2008, 8 (1)

[2] BIRCH JM, 1994, CANCER RES, V54, P1298

[3] Eeles RA, 1995, CANCER SURV, V25, P101

[4] Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation [J]. JOURNAL OF MEDICAL GENETICS, 2006, 43 (01) : 91 - 96

[5] LI FP, 1988, CANCER RES, V48, P5358

[6] Rare diseases, an emergent paradigm in the medicine of the XXI century [J]. MEDICINA CLINICA, 2010, 134 (04): : 161 - 168

[7] Germline TP53 R337H mutation is not sufficient to establish Li-Fraumeni or Li-Fraumeni-like syndrome [J]. CANCER LETTERS, 2007, 247 (02) : 353 - 355

[8] 2009 Version of the Chompret Criteria for Li Fraumeni Syndrome [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : E108 - E109

[9] Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome [J]. CANCER RESEARCH, 2006, 66 (16) : 8287 - 8292

[10] 2010, SERIE ENFERMEDADES R

[1] Association of the germline TP53 R337H mutation with breast cancer in southern Brazil [J]. BMC CANCER, 2008, 8 (1)

[2] BIRCH JM, 1994, CANCER RES, V54, P1298

[3] Eeles RA, 1995, CANCER SURV, V25, P101

[4] Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation [J]. JOURNAL OF MEDICAL GENETICS, 2006, 43 (01) : 91 - 96

[5] LI FP, 1988, CANCER RES, V48, P5358

[6] Rare diseases, an emergent paradigm in the medicine of the XXI century [J]. MEDICINA CLINICA, 2010, 134 (04): : 161 - 168

[7] Germline TP53 R337H mutation is not sufficient to establish Li-Fraumeni or Li-Fraumeni-like syndrome [J]. CANCER LETTERS, 2007, 247 (02) : 353 - 355

[8] 2009 Version of the Chompret Criteria for Li Fraumeni Syndrome [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : E108 - E109

[9] Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome [J]. CANCER RESEARCH, 2006, 66 (16) : 8287 - 8292

[10] 2010, SERIE ENFERMEDADES R